MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$2,809K
EPS
-$0.03
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Royalty
NaN NaN NaN 57,605
Product
NaN NaN NaN 118,329
Total revenues
272,551 164,677 211,007 NaN
Collaboration And License Revenue
NaN NaN NaN 2,941
Cost of product, collaboration and license sales, excluding amortization of acquired intangible assets
28,028 5,350* 15,781 11,420
Total revenues
NaN NaN NaN 178,875
Amortization of acquired intangible assets
11,581 9,349 7,534 4,061
Total revenues-Manufacturing
NaN NaN NaN 0
Research and development
100,873 133,128 100,158 112,990
Selling, general and administrative
86,183 96,874 84,046 85,262
Change in the fair value of contingent consideration
NaN -1,600* NaN NaN
Tangible asset impairment and losses on transactions, net
-927 10,275 -472 -99
Total operating expenses
227,592 236,026 207,991 213,832
Income from operations
44,959 -71,349 3,016 -34,957
Interest expense, net
-49,030 -55,188 -32,592 -30,358
Other income (expense), net
1,609 -12,546 6,502 -5,737
(gain) income before income tax expense
-2,462 -139,083 -23,074 -71,052
Income tax expense
347 -4,118 -38,970 -6,203
Net (gain) income
-2,809 -134,965 15,896 -64,849
Basic EPS
-0.03 -1.618 0.2 -0.83
Diluted EPS
-0.03 -1.328 0.2 -0.83
Basic Average Shares
82,521,023 83,398,965 78,471,119 78,151,240
Diluted Average Shares
82,521,023 101,593,445 87,115,369 78,151,240
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

US$136,516K All Other CountriesOther Than Russia...$44,596K BR$41,212K RU$3,249K Product$225,573K Royalty$46,835K Collaboration And LicenseRevenue$143K Net (gain) income-$2,809K (-100.32%↓ Y/Y)Total revenues$272,551K (-76.83%↓ Y/Y)(gain) income beforeincome tax expense-$2,462K (-100.26%↓ Y/Y)Income tax expense$347K (-99.45%↓ Y/Y)Income from operations$44,959K (-95.37%↓ Y/Y)Other income(expense), net$1,609K (125.52%↑ Y/Y)Total operatingexpenses$227,592K (10.55%↑ Y/Y)Interest expense, net-$49,030K (-43.82%↓ Y/Y)Research and development$100,873K (-7.43%↓ Y/Y)Selling, general andadministrative$86,183K (6.45%↑ Y/Y)Cost of product,collaboration and license...$28,028K (117.91%↑ Y/Y)Amortization of acquiredintangible assets$11,581K (204.92%↑ Y/Y)Tangible assetimpairment and losses on...-$927K (-1103.90%↓ Y/Y)

PTC THERAPEUTICS, INC. (PTCT)

PTC THERAPEUTICS, INC. (PTCT)